Palatin Reports Third Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update EX-99.1 2 ptn_ex991.htm PRESS RELEASE EXHIBIT 99.1 CRANBURY, NJ – May 15, 2024 /PRNewswire/ – Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system, today announced financial results for its fiscal third quarter ended March 31, 2024. "Study results of our successful Phase 3 M ...